Immune-mediated necrotizing myopathy after treatment with adalimumab in a patient with HLA-B27 ankylosing spondylitis

Neurologia (Engl Ed). 2020 Nov 5:S0213-4853(20)30296-6. doi: 10.1016/j.nrl.2020.09.003. Online ahead of print.
[Article in English, Spanish]
No abstract available

Publication types

  • Letter